共 29 条
- [1] Mager DE(2001)General pharmacokinetic model for drugs exhibiting target-mediated drug disposition J Pharmacokinet Pharmacodyn 28 507-532
- [2] Jusko WJ(2005)Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition Pharm Res 22 1589-1596
- [3] Mager DE(2008)Approximations of the target-mediated drug disposition model and identifiability of model parameters J Pharmacokinet Pharmacodyn 35 573-591
- [4] Krzyzanski W(2009)Target-mediated drug disposition model: approximations, identifiability of model parameters, and applications to the population pharmacokinetic––pharmacodynamic modeling of biologics Expert Opinion Drug Metab Toxicol 5 803-812
- [5] Gibiansky L(1993)Comparison of four basic models of indirect pharmacodynamic responses J Pharmacokinet Biopharm 21 457-478
- [6] Gibiansky E(1999)Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis J Pharmacokinet Biopharm 27 397-420
- [7] Kakkar T(2007)A review of the pharmacokinetics and pharmacodynamics of monoclonal antibodies––mechanistic modeling applied to drug development Current Opinion Drug Discov Devel 10 84-96
- [8] Ma P(2008)Monoclonal antibody pharmacokinetics and pharmacodynamics Clin Pharmacol Ther 84 548-558
- [9] Gibiansky L(2005)On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach Basic Clin Pharmacol Toxicol 96 182-192
- [10] Gibiansky E(2007)A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab Br J Clin Pharmacol 63 548-561